IVVvsPBE
iShares Core S&P 500 ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IVV | PBE | |
|---|---|---|
| Expense ratio | 0.030% | 0.58% |
| Assets | $881.6B | $414M |
| Net flow, 1 month | +$4.8B | +$15M |
| Net flow, 1 year | +$70B | +$114M |
| Return, YTD | +12.9% | +15.7% |
| Return, 1 year | +15.0% | +30.8% |
| Avg daily volume | 9.6M | 13K |
| Holdings | 507 | 31 |
| Listed | May 15, 2000 | Jun 23, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS